Curis
CRIS
#11106
Rank
โ‚ฌ0.58 M
Marketcap
0,30ย โ‚ฌ
Share price
-17.89%
Change (1 day)
-78.22%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -โ‚ฌ5.89 Million

According to Curis's latest financial reports the company's current earnings are โ‚ฌ7.06 Million. In 2025 the company made an earning of -โ‚ฌ4.69 Million, an increase over its 2024 earnings that were of -โ‚ฌ37.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ5.89 Million25.62%
2025 -โ‚ฌ4.69 Million-87.38%
2024 -โ‚ฌ37.12 Million-5.77%
2023 -โ‚ฌ39.39 Million-13.1%
2022 -โ‚ฌ45.32 Million27.52%
2021 -โ‚ฌ35.55 Million65.09%
2020 -โ‚ฌ21.53 Million-9.1%
2019 -โ‚ฌ23.69 Million-4.73%
2018 -โ‚ฌ24.86 Million-41.95%
2017 -โ‚ฌ42.82 Million-14.37%
2016 -โ‚ฌ50.01 Million3.55%
2015 -โ‚ฌ48.29 Million271.52%
2014 -โ‚ฌ13 Million76.64%
2013 -โ‚ฌ7.36 Million
2011 -โ‚ฌ6.25 Million27.76%
2010 -โ‚ฌ4.9 Million-43.87%
2009 -โ‚ฌ8.72 Million-23.44%
2008 -โ‚ฌ11.39 Million56.66%
2007 -โ‚ฌ7.27 Million-16.71%
2006 -โ‚ฌ8.73 Million-36.92%
2005 -โ‚ฌ13.83 Million156.25%
2004 -โ‚ฌ5.4 Million-37.24%
2003 -โ‚ฌ8.6 Million-93.34%
2002 -โ‚ฌ0.13 Billion86.79%
2001 -โ‚ฌ69.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.18 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.32 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ53.69 Million 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.87 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.27 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ19.26 Million 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ51.27 M-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA